Clinical Trial Update: CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for escalating treatment in intermediate and high-risk oropharyngeal cancer; currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oropharyngeal Cancer

Snippet

Sponsor: University of Birmingham | Conditions: Oropharyngeal Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING